Recent accretive acquisitions (notably Anadarko) are expected to progressively lower OXY's corporate breakeven and deliver cost-structure improvements and profitability upside over several years rather than immediately. A leadership transition is underway, posing execution risk but not offsetting the anticipated margin and breakeven benefits from the deals.
Recent accretive acquisitions (notably Anadarko) are expected to progressively lower OXY's corporate breakeven and deliver cost-structure improvements and profitability upside over several years rather than immediately. A leadership transition is underway, posing execution risk but not offsetting the anticipated margin and breakeven benefits from the deals.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
